|
The new site will focus on the use of AI models for purposes including the discovery and development of targeted medicines for patients with unmet medical needs.
|
 |
|
Aicuris’ overall revenue is anticipated to reach $500m by 2030, not including AIC468.
|
|
|
British people are increasingly turning to potentially unregulated weight loss medications as drug prices climb and waits for prescriptions lengthen.
|
|
|
Non-GLP-1 obesity drugs are emerging, with this landscape expected to surge 50-fold over the next five years, generating $15.5bn in 2031.
|
|
|
Under the Prescription Drug User Fee Act, the FDA has set a target action date of 17 August 2026.
|
|
|
In this issue: CDMOs use of digital twins to realise a strategic advantage, Physical AI's rise in pharma manufacturing, and more.
|
|
